Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults (Q24236739)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20238364%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

0 references

1 reference

title

Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20238364%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

main subject

anti-retroviral agent

0 references

author

Olalekan A. Uthman

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20238364%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

George W Rutherford

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20238364%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Nandi Siegfried

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20238364%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

publication date

17 March 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20238364%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

20 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20238364%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20238364%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

CD008272

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20238364%20AND%20SRC:MED&resulttype=core&format=json

CD4+ count-guided interruption of antiretroviral treatment

20 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008272.PUB2

Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4+ Cell counts and HIV RNA levels during follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008272.PUB2

Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008272.PUB2

Initiating highly active antiretroviral therapy in sub-Saharan Africa: an assessment of the revised World Health Organization scaling-up guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008272.PUB2

Influence of alternative thresholds for initiating HIV treatment on quality-adjusted life expectancy: a decision model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008272.PUB2

Antiretroviral treatment of HIV infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008272.PUB2

Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008272.PUB2

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008272.PUB2

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008272.PUB2

Effect of early versus deferred antiretroviral therapy for HIV on survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008272.PUB2

Randomized trials stopped early for benefit: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008272.PUB2

Should HIV therapy be started at a CD4 cell count above 350 cells/microl in asymptomatic HIV-1-infected patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008272.PUB2

Cost-effectiveness implications of the timing of antiretroviral therapy in HIV-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008272.PUB2

Significant improvements in self-reported gastrointestinal tolerability, quality of life, patient satisfaction, and adherence with lopinavir/ritonavir tablet formulation compared with soft gel capsules

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008272.PUB2

Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008272.PUB2

When to start antiretroviral therapy in resource-limited settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008272.PUB2

Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa

21 January 2018

1 reference

12 December 2020

Conservation of first-line antiretroviral treatment regimen where therapeutic options are limited.

1 reference

12 December 2020

When to initiate highly active antiretroviral therapy in low-resource settings: the Moroccan experience.

1 reference

12 December 2020

Survival Benefit of Initiating Antiretroviral Therapy in HIV-Infected Persons in Different CD4+ Cell Strata

1 reference

12 December 2020

HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy

1 reference

12 December 2020

Establishing CD4 thresholds for highly active antiretroviral therapy initiation in a cohort of HIV-infected adult Chinese in Hong Kong

1 reference

12 December 2020

10.1002/14651858.CD008272.PUB2

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

1553208

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20238364%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1553208

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20238364%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

PubMed publication ID

20238364

2 references

Consolidated OpenCitations Corpus – April 2017

1553208